Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation (Q43199840)

16 November 2017

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation (English)

1 reference

16 November 2017

arterial hypertension

1 reference

2

1 reference

16 November 2017

Olivier Sitbon

11

0 references

Marc Humbert

object named as

Marc Humbert

15

0 references

Gérald Simonneau

13

object named as

Gérald Simonneau

1 reference

16 November 2017

Dermot S. O'Callaghan

12

object named as

Dermot S O'Callaghan

1 reference

16 November 2017

4

Benjamin Sztrymf

1 reference

16 November 2017

3

Florence Coulet

1 reference

16 November 2017

1

Barbara Girerd

1 reference

16 November 2017

14

Florent Soubrier

1 reference

16 November 2017

Azzeddine Yaici

5

1 reference

16 November 2017

Xavier Jaïs

6

1 reference

16 November 2017

David Tregouet

7

1 reference

16 November 2017

Abilio Reis

8

1 reference

16 November 2017

Valérie Drouin-Garraud

9

1 reference

16 November 2017

Alain Fraisse

10

1 reference

16 November 2017

language of work or name

English

0 references

publication date

7 January 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

16 November 2017

1 reference

16 November 2017

181

1 reference

16 November 2017

851-861

1 reference

16 November 2017

8

1 reference

Treatment of pulmonary arterial hypertension

16 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Update in pulmonary hypertension 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

The pulmonary vascular complications of hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Genes and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200908-1284OC

10.1164/RCCM.200908-1284OC

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference